LGALS3 and early-onset autosomal dominant Alzheimer disease: More importantly, in Alzheimer’s disease Galectin-3 appear to be one of the key molecules in microglial activation and Galectin-3 deletion in AD prone mice attenuate microglia associated TLR dependent immune response, amyloid β burden and improves cognitive functions.